852 related articles for article (PubMed ID: 25552286)
21. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
[TBL] [Abstract][Full Text] [Related]
22. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
23. Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children.
Udaka YT; Yeh-Nayre LA; Amene CS; VandenBerg SR; Levy ML; Crawford JR
J Neurosurg Pediatr; 2013 Feb; 11(2):119-26. PubMed ID: 23157391
[TBL] [Abstract][Full Text] [Related]
24. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP
J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519
[TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
Cheng W; Ren X; Zhang C; Han S; Wu A
J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Nahed BV; Redjal N; Brat DJ; Chi AS; Oh K; Batchelor TT; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):609-30. PubMed ID: 26530264
[TBL] [Abstract][Full Text] [Related]
27. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study.
Meimand SE; Pour-Rashidi A; Shahrbabak MM; Mohammadi E; Meimand FE; Rezaei N
World Neurosurg; 2022 Jan; 157():e123-e128. PubMed ID: 34607064
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers in low-grade gliomas: predictive or prognostic?
Hartmann C; Hentschel B; Tatagiba M; Schramm J; Schnell O; Seidel C; Stein R; Reifenberger G; Pietsch T; von Deimling A; Loeffler M; Weller M;
Clin Cancer Res; 2011 Jul; 17(13):4588-99. PubMed ID: 21558404
[TBL] [Abstract][Full Text] [Related]
29. Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients.
Lehrer S; Rheinstein PH; Rosenzweig KE
Clin Neurol Neurosurg; 2018 Sep; 172():112-115. PubMed ID: 29986195
[TBL] [Abstract][Full Text] [Related]
30. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
31. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D
Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370
[TBL] [Abstract][Full Text] [Related]
32. Current management of low-grade gliomas.
Hottinger AF; Hegi ME; Baumert BG
Curr Opin Neurol; 2016 Dec; 29(6):782-788. PubMed ID: 27676279
[TBL] [Abstract][Full Text] [Related]
33. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
34. Molecular predictors of outcome in low-grade glioma.
Weiler M; Wick W
Curr Opin Neurol; 2012 Dec; 25(6):767-73. PubMed ID: 23160425
[TBL] [Abstract][Full Text] [Related]
35. The management of low-grade gliomas in adults.
Morshed RA; Young JS; Hervey-Jumper SL; Berger MS
J Neurosurg Sci; 2019 Aug; 63(4):450-457. PubMed ID: 30916536
[TBL] [Abstract][Full Text] [Related]
36. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
37. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M
Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903
[TBL] [Abstract][Full Text] [Related]
38. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
Wrensch M; Rice T; Miike R; McMillan A; Lamborn KR; Aldape K; Prados MD
Neuro Oncol; 2006 Jan; 8(1):12-26. PubMed ID: 16443944
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]